Multiple births from artificial insemination in Switzerland have decreased from 17.4% to 2.8% over two decades, following 2017 reproductive medicine law changes.
"This decline can largely be explained by a revision of the Reproductive Medicine Act in 2017. It allows a higher number of embryos (maximum 12) to be stored."
The era of the "IVF twin boom" in Switzerland has effectively ended. In a staggering shift that underscores the rapid evolution of reproductive technology, the rate of multiple births following artificial insemination has collapsed from a high of 17.4% in 2002 to a mere 2.8% in 2023. This is not a statistical anomaly; it is a calculated victory for Swiss medicine. For decades, multiple pregnancies were the risky, unintended hallmark of IVF treatments, often leading to complications for both mothers and infants. Today, that narrative has been rewritten.
The data, released by the Federal Statistical Office (FSO), paints a picture of a medical sector that has gained unprecedented control over biological outcomes. While the total number of couples seeking treatment remains high, the volatility of the results has vanished. We are witnessing a transition from a game of probability to a practice of precision. The days of transferring multiple embryos in a desperate bid for successāresulting in high-risk twin or triplet pregnanciesāare largely behind us. Switzerland has successfully decoupled high success rates from high-risk multiple births, setting a new standard for patient safety in reproductive health.
This dramatic statistical nosedive is the direct result of decisive political action. The turning point was the 2017 revision of the Reproductive Medicine Act, a piece of legislation that fundamentally altered the toolkit available to Swiss fertility specialists. Prior to this law, doctors were often forced to transfer multiple embryos immediately due to restrictive storage laws. The 2017 overhaul changed the game by allowing the storage of up to 12 embryos.
Tonia Rihs of the FSO's Reproduction Statistics Section confirms that this legislative flexibility is the primary driver behind the trend. By allowing for the development and storage of more embryos, medical teams can now observe and select the single most viable candidate for implantation. This "quality over quantity" approach was previously legally difficult to execute. The law has empowered science to catch up with ethics, ensuring that the desire for a child does not force parents into the medical complexities of carrying twins. It is a prime example of how forward-thinking legislation can have immediate, tangible benefits on public health outcomes.
The shift in clinical practice has been nothing short of seismic. The "single embryo transfer" (SET) has moved from being a cautious option to the overwhelming standard of care in Switzerland. The numbers illustrate a complete reversal of methodology. In 2017, the medical community was still in transition, with 4,085 double embryo transfers edging out 3,789 single transfers. Fast forward to 2023, and the landscape is unrecognizable.
Last year, single embryo transfers surged to 7,341, while double transfers plummeted to just 811. This represents a massive change in risk management and medical philosophy. Doctors are no longer hedging their bets by implanting two embryos. Instead, they are leveraging advanced diagnostics to identify the one embryo with the highest potential for life. This strategic pivot explains why the twin rate has crashed. The Swiss medical community has effectively decided that a healthy singleton is the gold standard of success, aggressively moving away from the "two for the price of one" mentality that previously characterized IVF treatments.
Critics might fear that transferring fewer embryos would lower the chances of pregnancy, but the data proves the exact opposite. Efficiency in Swiss fertility clinics has reached an all-time high. Despite a 1.5% drop in the number of couples treated (6,513 in 2023), the actual number of babies born increased by 5.9%, totaling 2,511 children. These IVF babies now constitute a significant 3% of all births in the nation.
The success rate per transfer has climbed steadily, rising from 23% in 2017 to 30% in 2023. This is a critical validation of the single-embryo strategy. It demonstrates that better selection methods yield better results than simply increasing the number of embryos transferred. Switzerland is proving that in the realm of assisted reproduction, less is indeed more. With 67 of these children born via sperm donation, the scope of assisted parenthood continues to widen. As technology advances, we can expect these success rates to climb even further, cementing Switzerland's status as a leader in safe, effective reproductive medicine.